Daniel Hampu

Excited for our webinar tonight: Investing in Healthcare Startups: An Angel Perspective When: tonight at 6 pm eastern Where: https://lnkd.in/dPUFNbhe We had had a couple last minute changes and I am very excited to have an engaging conversation with Thanasi Tsiodras, Dr. Shaun Kuan and Regina Prasad, MS. We will be discussing: 1. How to start investing in startups 2. Lessons from your winners and losers 3. What are some red flags in a startup 4. What is your diligence process like? 5. How do you get deal flow?  6. What is the ideal angel investor archetype? Who should invest in startups and who shouldn't. #healthcare #venturecapital #angelinvesting

30

9 Comments

There appears to be a "Superstar Effect" in healthcare and biomedical AI research right now. A small percentage of publications are truly novel methods contributions that introduce new capabilities or behaviors; whereas a majority of contemporary research publications are focused on implementation science to assess the real-world utility and performance of new methods. This dynamic seems different from prior eras, when the translational infrastructure for implementing novel AI methods was largely unavailable. While methods research often captures more attention and accolades, both types of research are critical – novel methods without implementation science lacks translatability; implementation science without novel methods lacks novelty. If our goal is to invent and deploy transformative AI methods in real-world healthcare and life sciences contexts, we ought to continue encouraging and rewarding stellar implementation science work alongside breakthrough methods development.

90

3 Comments

Should you sell your practice to a VC-Backed MSO Startup? tldr: - new VC-backed startups are forming MSOs to roll up independent practices - The pitch is physicians receive early liquidity from the roll up and are granted ESOP shares that can be used for retirement - Problem is the use of ESOPs with independent practices is not a new concept and has been used with large group practices since the 70's - ESOPs do not grant full ownership and in order for the shares to be valuable for retirement, the practice needs to run the same if not better post roll up - With VC-backed startups being primarily operated by non-physicians with zero clinical or medical practice experience, the likelihood of this happening is extremely low making the entire concept high risk However, there is a viable path for continued ownership + liquidity for independent practices. Check out the article to learn more. ⤵ https://lnkd.in/gmGvTYwP

7

3 Comments

Leading US VC General Catalyst just acquired the health system Summa Health for $485 million. Summa Health is a nonprofit #healthcare system with over 30 locations in Ohio (US). This analysis has been made possible thanks to the data platform HealthTech Alpha from Galen Growth | Insights You Can Trust. I wrote down a few thoughts: 1️⃣ 𝐆𝐞𝐧𝐞𝐫𝐚𝐥 𝐂𝐚𝐭𝐚𝐥𝐲𝐬𝐭 𝐢𝐬 𝐩𝐥𝐚𝐧𝐧𝐢𝐧𝐠 𝐭𝐨 𝐛𝐮𝐢𝐥𝐝 𝐚 𝐝𝐢𝐠𝐢𝐭𝐚𝐥-𝐟𝐢𝐫𝐬𝐭 𝐜𝐚𝐫𝐞 𝐝𝐞𝐥𝐢𝐯𝐞𝐫𝐲 𝐦𝐨𝐝𝐞𝐥 𝐥𝐨𝐜𝐚𝐥𝐥𝐲 The health system Summa Health will be used as a testing field for the wide HealthTech portfolio of General Catalyst. General Catalyst, through its subsidiary HATCo, has committed an additional $550 million over the next five years for strategic investments and innovation. I had a similar case in my network of a PE fund that owned both a health system and a portfolio of HealthTech companies. On paper, this was the perfect match. In reality, it failed. 2️⃣ 𝐓𝐡𝐞 "𝐎𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐬𝐲𝐬𝐭𝐞𝐦" 𝐰𝐢𝐥𝐥 𝐛𝐞 𝐚𝐭 𝐭𝐡𝐞 𝐜𝐨𝐫𝐞 𝐨𝐟 𝐭𝐡𝐞 𝐭𝐫𝐚𝐧𝐬𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧 General Catalyst includes Commure in its portfolio. Over the past several years, Commure has integrated data from various systems, including all major EHRs, to become the interoperable operating system used by many leading hospitals across the U.S. One immediate application will be implementing Scribe (based on Commure), an AI-powered tool for automatic clinical documentation co-developed with HCA Healthcare. 3️⃣ 𝐆𝐞𝐧𝐞𝐫𝐚𝐥 𝐂𝐚𝐭𝐚𝐥𝐲𝐬𝐭'𝐬 𝐩𝐨𝐫𝐭𝐟𝐨𝐥𝐢𝐨 𝐡𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭: 𝟏 𝐛𝐢𝐠 𝐬𝐮𝐜𝐜𝐞𝐬𝐬 𝐚𝐧𝐝 𝟏 𝐛𝐢𝐠 𝐟𝐚𝐢𝐥𝐮𝐫𝐞 GC invested in Livongo, a telehealth solution for diabetes management, that was acquired by Teladoc for $18 billion (though Teladoc is now valued at only $1.7 billion!). Livongo was the perfect exit before the HealthTech downturn. On the other hand, GC has been a major investor in Olive AI, a BPO and care automation company for hospitals. Despite being valued at over $4 billion in 2021, Olive AI went bankrupt in 2023. Commure is now GC's new bet in care operations, informed by lessons from Olive AI's failure. 4️⃣ 𝐀 𝐕𝐂 𝐨𝐰𝐧𝐢𝐧𝐠 𝐚 𝐡𝐞𝐚𝐥𝐭𝐡 𝐬𝐲𝐬𝐭𝐞𝐦: 𝐰𝐢𝐧𝐧𝐢𝐧𝐠 𝐫𝐞𝐜𝐢𝐩𝐞 𝐨𝐫 𝐝𝐲𝐬𝐭𝐨𝐩𝐢𝐚𝐧 𝐬𝐜𝐞𝐧𝐚𝐫𝐢𝐨? The debate over private investors owning parts of the healthcare system (and potentially prioritizing profits over patient care) is intense (both in the US and Europe). Personally, I am quite excited about this move. And VCs are not PEs: While private equity firms aim to optimize the profitability of an established healthcare asset within five years for a high-multiple resale, venture capitalists focus on increasing the value of their HealthTech portfolio by demonstrating how these solutions bring real-world value. I am not naive though: I know that VCs do not act in the general interest. But we need them to drive innovation in healthcare. #healthcare #healthtech #vc #hospital #transformation

199

10 Comments

We’re on the brink of a healthcare revolution; Generative AI is about to save hundreds of thousands of lives. However, the transformation won’t happen unless doctors, patients, and leaders unite. In the latest episode of The Business of AI in Healthcare Podcast, Robert Pearl, M.D. — a visionary healthcare leader and former CEO of one of the largest medical groups in the U.S. — reveals how Generative AI is transforming medicine, based on insights from his new book, ChatGPT, MD. In this episode, he reveals mind-blowing insights that every healthcare professional should know: 🩺  Generative AI isn’t just a tool—it’s poised to save hundreds of thousands of lives by preventing heart attacks, strokes, and cancer before they happen.  🌐  AI’s power is doubling every year—in 5 years, it will be 32x stronger, and in 10 years, 1,000x more powerful. The future of healthcare is moving faster than we can imagine!  🏥  The chronic disease epidemic—diabetes, hypertension, heart disease—could be managed by a triad of physicians, patients, and AI tools that provide real-time monitoring and personalized treatments, reducing deaths by up to 50%. Healthcare 4.0 isn’t coming—it’s here, and this episode shows how AI is reshaping the future of patient care. 👁‍🗨 🔗 Learn More about Robert Pearl, M.D. at: https://robertpearlmd.com/ 📚 Get your copy of ChatGPT, MD here: https://lnkd.in/ewVW3CJF Think you’ve seen it all in healthcare? Think again. Subscribe and discover AI’s game-changing impact: Listen to the full episode on: - Website: https://lnkd.in/eCbME_bf - Spotify: https://lnkd.in/eNY4rJkB - Apple Podcast: https://lnkd.in/e8iwkZrZ #HealthcareAI #EmotionalIntelligence #AIinHealthcare #HealthcareProviders #AIandHealthcare #BusinessofAIinHealthcarePodcast #HealthcarePodcast #HealthcarePodcast

47

2 Comments

This year, Femtech companies are on track to surpass the industry's 2021 fundraising record of $1.9 billion. This is great news for an sector that serves women and where 80% of the founders are female. 🎉 We’re celebrating three women-founded and led Femtech companies who are leading the investment wave in 2024: Virtual care clinic Midi Health helps women navigate midlife hormonal changes. Midi is now accepted by all major insurance companies, and it’s available in all 50 states. In 2024, Midi raised $60 million in a Series B round of funding. Malaica is revolutionizing maternal healthcare through its holistic, tech-enabled care experience. The Kenyan-based company raised $1 million in pre-seed funding this year. With Gabbi's AI-powered risk assessment, women can “catch breast cancer sooner,” and receive a personalized action plan. Gabbi has raised $5.4 million with its most recent funding round in 2024. There are over 1,800 Femtech companies worldwide - who's on your radar for 2025? #femtech #womenshealth #digitalhealth #womenintech #healthtech #womensdigitalhealth

9

Exciting news from Monica Chopra, Jeffrey De Flavio, MD, Samantha Adelberg, and the rest of the Auxa Health team as they officially announce their $5.2M Seed round. The team's deep industry expertise and drive for change have led them to solve critical infrastructural friction to providing quality healthcare and adoption of value-based care. Auxa's AI benefit navigation platform is simplifying the complexities of healthcare by streamlining all of the fragmented and siloed data and information to make it actionable in real-time for healthcare organizations. For the 70% of Americans who aren't getting access to the health and social care benefits they deserve, Auxa's solution will be pivotal in enabling equitable care. We're thrilled to partner with co-investors Zeal Capital Partners, AlleyCorp, Laconia, and Chaac Ventures on this journey and look to share many more milestones ahead. Cc K50 Ventures, Ryan Bloomer, Daniel Vásquez, Nick Talwar, Stefanie Ng https://lnkd.in/dPDY7-Db

44

4 Comments

Some VC investors believe that brick and mortar - referring to a physical presence of some kind - should be avoided at all costs. Yet, the track record of clinic and hybrid care businesses in health care indicates otherwise. ==> One Medical (sold for $3.9 billion to Amazon), Oak Street (bought by CVS for $10.6 billion), Lifestance (IPO at $7.5 billion market cap), and PE-backed Premise Health (acquired by OMERS Private Equity for $1.1 billion) If a clinic is indicated as the optimal way to deliver care for that patient population, there are creative ways to build and operate them. Full article below with advice and strategies on how to build and operate hybrid clinics from my teammate Anarghya Vardhana from Maveron, Amir Dan Rubin from OneMedical Group, Steven Eidelman from Modern Animal and more!

13

1 Comment

This partnership will help you know how food affects your health 🥗 ŌURA (wearable ring that tracks health data) and Dexcom (continuous glucose monitoring device maker) are working together and integrating their data and biosensors so users can adjust behaviors to positively impact their #biometrics and long term health. Dexcom has also invested $75 million into Oura Series D funding round - increasing their valuation to $5 billion. Oura had stated they sold 2.5 million rings earlier this year and is predicting their annual sales to double end of this year. This partnership can help people understand the link between activity 💪, sleep 💤 , nutrition 🍲, and glucose 🍭. Our society continues to care more about our bodies and health, and I believe this will move the needle for the #holistichealth industry. Looking forward to trying out the new technology once released in 2025. #healthtech #wellness #startupjourney

19

3 Comments

💥 New Episode: Second Opinion with Caroline Pearson, Executive Director of Peterson Health Technology Institute (PHTI)! Remember that bombshell PHTI report showing many digital diabetes companies aren't producing meaningful improvements in patient outcomes—and are even driving up healthcare costs?? We had a candid chat with Caroline about how the industry can do better. Some takeaways: 📊 Prove Your Worth: "Digital" isn't a value proposition—it's table stakes. Whether you're driving clinical outcomes or providing patient support, back your claims with evidence and be crystal clear about what you're actually delivering. 🏥 Healthcare is Unaffordable: Caroline talks about the tough trade-offs we make every day due to finite resources. If we’re going to spend healthcare dollars, let’s make sure it’s on something that delivers real value. 🤝 Collaboration is Key: Caroline emphasizes the need for companies to work together—don’t compete when it comes to building evidence. Let’s all push towards better solutions for patients! Check out the full episode here and let us know what you think: ᯤ https://lnkd.in/gUmfWSPq  https://lnkd.in/g7FdqZhs ⏵ https://lnkd.in/gnGH7dpt Turpentine Christina Farr Luba Greenwood, J.D.

54

2 Comments

🎙️ Thrilled to share that V. Tyrone Lam, COO of GATC Health, was recently featured on the Innovation Wave Podcast! In this insightful 20’ episode with Bob McGriff and me, Ty delves into how AI-driven predictive analytics can transform our approach to disease treatment, making it more proactive and less risky. He shared compelling insights on the future of healthcare and how predictive tools can lead to earlier interventions and better patient outcomes. A must-listen for anyone interested in the cutting-edge of medical technology and AI! 👉 Check out the episode to learn more about Tyrone's vision and GATC Health's pioneering work in this exciting field. Let's discuss how these innovations are reshaping the landscape of healthcare! #HealthTech #AI #PredictiveAnalytics #Innovation

30

11 Comments

This is a pretty wild statistic. After 10 years of the MedTech Innovator program, 96% of program graduates are either still in business, or have been acquired. For a community made completely of MedTech startups, this is truly impressive. Applications for the 2025 cohort are open now! #MedTech #HealthTech #DigitalHealth #Innovation #AI #ML #StartUp #Fundrasing https://lnkd.in/gC97Q5K8

54

1 Comment

Digital Health Wire has the news today on K Health's amazing momentum as the company is building on the debut of its AI Knowledge Agent with the close of $50M in equity funding led by Claure Group. K Health is on a mission to provide access to high-quality #medicalcare at scale by using AI to turn patient smartphones into the first stop along their care journey. The company's clinical-grade #AI for #primarycare takes patients through a personalized chat to walk through their symptoms, develops an assessment grounded in the #EHR, then delivers insights to providers to inform their diagnoses and treatments. This allows providers to practice at the top of their license and engage with their patients instead of spending valuable time manually piecing together relevant information. Digital Health Wire had the exclusive news on K’s AI Knowledge Agent when it was unveiled. This breakthrough tech is composed of an array of LLMs boosted by K Health’s own advanced algorithms, with key differentiators from standard AI applications. Congratulations Allon Bloch, Ran Shaul, Ethan Fischer, and the K Health team on this funding, which will be used to fuel more health system partnerships and continue sharpening K Health's first-of-its-kind AI, which should in turn allow it to make a compelling ROI case. https://lnkd.in/gvcyaFbU #digitalhealth #KHealth #AIinHealthcare #artificialintelligence #

16

1 Comment

Healthcare tech founders are some of the brightest minds in the industry—innovators with incredible technical acumen. But too often, they’re bogged down in tasks and minutiae that pull them away from their true strengths. 💪 When founders are spending their time on business operations, strategic planning, and high-level decision-making, they aren’t focused on the innovation that sets their company apart. That’s where fractional representation changes the game. By bringing in seasoned executives — fractional CEOs, COOs, and CMOs — you free up your time to focus on what you do best while ensuring that your business is strategically guided by experts who know how to scale, build partnerships, and manage operations. Your technical expertise drives innovation. Let me handle the business of growth. 📈 What parts of your business do you struggle with the most (and wish you had more help with)?

21

4 Comments

🌟 Exciting News! 🌟 I just read an insightful article by **Kyle Wiggers** about Canva’s recent acquisition of **Leonardo.ai**, and I couldn’t be more excited about what this means for the future of design and AI! Canva is taking a huge leap in its generative AI capabilities by bringing Leonardo.ai’s expertise in AI-driven content creation into the fold. What stands out to me is the way Leonardo.ai offers users incredible control over image creation, blending text prompts with real-time sketching using its **Live Canvas** feature. Imagine the possibilities this will bring to industries like fashion, advertising, and architecture! Canva plans to integrate these capabilities into its **Magic Studio** suite, expanding the tools available for creators and making AI-driven design more accessible than ever. This acquisition speaks volumes about Canva’s commitment to staying at the forefront of AI-powered creativity. It’s clear that Canva is not just thinking about today but also investing in the future of design technology. With over **19 million users** already on Leonardo.ai’s platform, the potential is enormous! If you haven’t read Kyle’s article yet, I highly recommend checking it out. The article can be found on TechCrunch.com. It really got me thinking about how generative AI can empower creators in new ways. What are your thoughts on AI in design? Let’s discuss! 💡 #AI #GenerativeAI #Canva #LeonardoAI #TechInnovation #CreativeDesign #AIinDesign #KyleWiggers

3

What you won’t find: Wheel powering any of the sketchy DTC GLP-1 compounding companies. What you will find: This market exists because companies like Wheel, who prioritize clinical quality and regulatory compliance in every process and product, refuse to take shortcuts. We're committed to ensuring that patients receive high-quality care—not just drive quick profits. Sometimes, choosing ethics over revenue means we don't see a short-term windfall during a "Gold Rush." But as CEO, I can assure you that it also means that patients, customers, and clinicians can trust that Wheel is always on the right side of history. I believe GLP-1s will transform healthcare as profoundly as AI, and Wheel is dedicated to being at the forefront—delivering compliant, accessible, and responsible care.

97

3 Comments

"Move fast and break things? Not in healthcare." A hospital CEO raised his hand and said from the crowd. (I was addressing a room full of providers on AI's potential in healthcare.) As a YC alum and multi-time founder, I've seen tech revolutionize industries. But healthcare? The stakes are higher. Lives are on the line. The CEO's concern echoed across the room: "We can't afford Silicon Valley's 'move fast and break things' mentality when millions of lives are at stake." Fair point. But here's where it gets interesting. I asked, "Who here wants to learn more about AI in healthcare?" Every hand shot up. The enthusiasm was palpable. These professionals weren't resistant to change. They were hungry for knowledge. So, I flipped the script: "What if AI could help you move carefully and fix things?" Silence. Then a flood of questions. They asked how AI could: - Automate routine tasks, to free up clinicians to spend more time with patients - Improve diagnostic accuracy - Streamline administrative processes — for doctors, RCM, and patient access teams But the key? Safety and security at every step. I shared our approach: - Rigorous testing protocols (thanks to our CTO's background in self-driving cars) - Always-on human oversight - HIPAA compliance, HITRUST certification, and end-to-end encryption The skepticism turned to intrigue. This interaction showed me that healthcare innovation requires a delicate balance. We need to address people's concerns while showcasing possibilities. The future of healthcare isn't just about new technology. It's about building trust, ensuring safety, and keeping sight of what matters most: the patients we serve.

30

2 Comments

Latest #PitchBook data for #HealthIT investment shows a preference for later stage investment across healthIT that pre-dates the VC downturn and current interest rate environment. Even though healthIT has been more resilient to current headwinds compared to health care services and PPM plays, perhaps it speaks to a need to scale solutions and points of saturation for new entrants. "...In the lower middle market, we are beginning to see more examples of a phenomenon we have anticipated for a while: PE firms and PE-backed companies acquiring VC-backed startups. Lower-middle-market PE firms perennially complain that VC- backed companies expect too-high multiples, and these firms would generally prefer to invest on a multiple of EBITDA rather than a multiple of revenue..." Speaks to a convergence that would allow PE-VC M&A on both ends of the startup spectrum. #HealthcareVC #healthcarePE

1

1 Comment

#Niche-focused #ventures in #HealthTech, such as those #targeting #underserved areas or #specific health conditions, offer several benefits. They can address gaps in the #healthcare system, provide specialized care, and #potentially integrate into broader #ecosystems for comprehensive healthcare solutions. For example, #JVEDTECHMedovation, could explore #partnerships with #niche #HealthTech startups to enhance offerings in healthcare #innovation.

1